Challener, Gregory J. https://orcid.org/0000-0002-2844-4661
Myasoedova, Elena
Crowson, Cynthia S.
Giblon, Rachel E.
Atkinson, Elizabeth J.
Davis, John M. III
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01 AR46849, R01 AG034676)
Article History
Received: 4 June 2021
Revised: 16 August 2021
Accepted: 7 September 2021
First Online: 11 September 2021
Declarations
:
: This study was approved by the institutional review boards of Mayo Clinic (IRB no. 17–002593) and Olmsted Medical Center (IRB no. 017-OMC-17) and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.
: Dr. John M Davis, III was supported by research grants from Pfizer and served on advisory boards for AbbVie and Sanofi-Genzyme. Dr. Cynthia Crowson was supported by a Pfizer research grant. The other authors have disclosed no conflicts of interest.